Ultrasound device for local inhibition of pain conduction
A piezoelectric ultrasound device with specific frequency and divergence angles creates a localized anesthesia zone near the skin surface, addressing the limitations of existing neurostimulation devices and anesthetics by providing effective and temporary pain relief.
Patent Information
- Application Number
- DE102023120463
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-08-01
- Publication Date
- 2024-11-14
- Estimated Expiration
- 2043-08-01
AI Technical Summary
Existing neurostimulation devices using ultrasound frequencies above 1 MHz are not well suited for nerve stimulation or inhibition, and existing anesthetics have duration issues and can be costly, with some patients avoiding medical procedures due to fear.
A piezoelectric ultrasound device generating pulsed ultrasound with frequencies between 100 kHz and 900 kHz, divergent angles between 20° and 70°, and intensity averaging 20-100 mW/cm² to create a pain-insensitive zone near the skin surface through mechanical excitation of nerve cells.
Effectively inhibits pain conduction by creating a localized anesthesia zone up to 1.5 cm deep without thermal effects, allowing for precise and temporary pain relief during procedures like injections and biopsies.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
[0001] The invention relates to an ultrasound device for medical purposes, comprising at least one piezoelectrically operated ultrasound transducer, an electrical voltage source, and a control device configured to apply a predetermined voltage signal to the at least one ultrasound transducer. The invention also relates to a device for locally anesthetizing the tissue of a living patient for a medical procedure, for example, for an injection.
[0002] As early as 1929, EN Harvey published a series of observations on the "stimulation of nerves" and muscles with ultrasound. Since then, numerous scientific experiments in vitro and in vivo have demonstrated that nerve cells can be stimulated by ultrasound irradiation, in particular, they can be activated to fire or temporarily prevented from firing. See Blackmore et al., "ULTRASOUND NEUROMODULATION: A REVIEW OF RESULTS, MECHANISMS AND SAFETY," Ultrasound in Med. & Biol., Vol. 45, No. 7, pp. 1509-1536, 2019, https: / / doi.org / 10.1016 / j.ultrasmedbio.2018.12.015. Common approaches to neurostimulation (NS) aim at electrical, magnetic, chemical, thermal, and / or mechanical signal generation. This can be achieved by various technical means, such as contact electrodes, magnetic coil arrangements (especially for transcranial NS), administration of pharmaceuticals, local heating by illumination (e.g.Infrared) or vibrators. In particular, handheld ultrasound massagers for self-application by the user are available on the market. These are essentially intended for localized heating of tissue through the application of ultrasound (US). Such devices typically operate at ultrasound frequencies greater than 1 MHz and are therefore not well suited for NS.
[0003] US neurostimulation can be performed using low-energy US irradiation, which can only marginally increase tissue temperature. In living tissue, the deposited energy is transported away from the site of irradiation and dissipated within a very short time through fluid transport processes. Therefore, no noticeable heating occurs. Rather, the relevant mechanism for the activation and inhibition of irradiated nerve cells is thought to be the mechanical effect on the cells' ion channels, which influences the electrical potential within the cells. Depending on the US parameters, the potential can be increased or decreased, causing the cells to either fire repeatedly in rapid succession or, alternatively, to fire practically never. If the US irradiation is deactivated, the nerve cells return to their normal behavior after a short time.
[0004] This represents a significant advantage of US inhibition of pain conduction over the traditional administration of an anesthetic. In addition to the cost of the anesthetic, the duration of its effect is often disproportionate to the duration of the procedure, such as an injection into a blood vessel. Nevertheless, for some patients, the "fear of the needle" is reason enough to avoid doctor visits.
[0005] Furthermore, US 2012 / 0 203 141 A1 discloses a ring-shaped vibrating element for blocking pain in a patient's finger. The vibrating element can be temporarily placed around a finger and has a control unit and a vibration element, which can include an ultrasonic transducer, for introducing a targeted vibration into the finger. The introduction of vibrations is intended to block or reduce the transmission of pain along the finger, for example, when a blood sample is to be taken from a diabetic's finger for a blood glucose measurement.
[0006] US 2013 / 0 006 153 A1 discloses a flat ultrasonic transducer with a piezoelectric component that receives a control signal from an energy generation module and then specifically emits ultrasonic energy. The sound emission can be controlled in such a way that the direction and wave pattern of the ultrasonic energy emitted by the piezoelectric component can be varied.
[0007] Furthermore, US 2016 / 0 016 012 A1 discloses a stimulation device with a plurality of transducers for emitting low-intensity ultrasound beams and with a mounting device to which the ultrasound transducers are attached and which allows the ultrasound transducers to be attached to a patient's upper body. The emitted ultrasound radiation can be focused, in particular, such that the spinal cord or the nerves surrounding the spinal cord are stimulated with low-intensity ultrasound.
[0008] Furthermore, according to the publication "Guo, H., Offutt, SJ, Hamilton II, M. et al. Ultrasound does not activate but can inhibit in vivo mammalian nerves across a wide range of parameters. Sci Rep 12, 2182 (2022)," ultrasound has been shown to stimulate cerebral circuits. However, the ability to excite peripheral nerves with ultrasound is controversial. The aforementioned article shows that ultrasound cannot excite an isolated mammalian sciatic nerve in an in vivo preparation, even at high pressures and for a wide range of parameters, including different pulse patterns and center frequencies. However, ultrasound is supposedly able to reliably inhibit nerve activity, with greater suppression correlating with an increase in nerve temperature.
[0009] The object of the invention is therefore to propose a device for local anesthesia or for inhibiting pain conduction based on neurostimulation by means of ultrasound. This object is achieved by an ultrasound device for local inhibition of pain conduction comprising at least one piezoelectric ultrasound generator with a contact surface for ultrasound-transmitting contact with the skin surface of a patient, an electrical voltage source, and a control device for applying predetermined voltage signals to the at least one ultrasound generator, characterized in that a. the control device is designed to cause the at least one ultrasound generator to generate pulsed ultrasound with an ultrasound frequency from the interval of 100 kHz to 900 kHz b. and a pulse duration from the interval of 0.1 to 3 milliseconds, where c. maximum 30 pulses per second with equal pulse spacing d. with an ultrasound intensity averaged over the pulse interval from the interval of 20 to 100 mW / cm 2 be generated and e. Means are provided for setting up a divergent ultrasonic radiation with a predetermined radiation direction, which has an angle of incidence Φ inc between 20° and 70° with the normal of the contact surface, where the angle of incidence Φ inc and an opening angle of the divergent ultrasonic radiation Φ div are chosen such that the condition Φ inc + Φ div ≈ 90 is satisfied, so that the angle of incidence Φ inc at least approximately the complement angle of the opening angle of the divergent ultrasonic radiation Φ div corresponds.
[0010] The subclaims specify advantageous embodiments of the ultrasound device. The invention utilizes the inventor's empirical finding that a laterally inclined ultrasound beam with the aforementioned US parameters and a sufficient degree of divergence results in a pain-insensitive zone—also referred to as an anesthetic zone—being created in the skin along the beam direction next to the ultrasound generator, as long as the radiation is active. The anesthetic zone can extend from the skin surface to a depth of approximately 1.5 cm and corresponds to the area in which existing nerve cells are exposed to sufficient intensity to inhibit pain conduction. In order to also anesthetize nerves close to the skin surface, the divergence of the radiation is essential.
[0011] The term "divergence" refers to the natural broadening of the sound beam with increasing distance from the transducer. This means that the sound diverges the further it is from the source, spreading the sound energy over a larger area, resulting in a geometrically determined decrease in intensity in the wavefront.
[0012] The opening angle of the divergent beam, which can be considered as a measure of divergence, depends on the dimensions of the transducer and on the frequency or wavelength λ of the ultrasonic radiation according to the formula: sinΦdiv=1.22λd=1.22cf d d - diameter of the transducer f - frequency of ultrasound c - speed of sound (here: in living tissue > 1500 m / s)
[0013] To successfully inhibit pain sensation, neuroreceptors very close to the skin surface must be irradiated with ultrasound. To achieve this, beam divergence alone is not sufficient; the ultrasound must also be directed at an angle of incidence Φ inc > 0 relative to the normal of the contact surface. For simplicity, the contact surface is always assumed to be a flat surface.
[0014] The following figures serve to further explain this. They show: Fig. 1 a schematic sketch of the ultrasound irradiation from a single piezo element through an angled shaped attachment via the contact surface on the underside of the attachment into a living skin tissue; Fig. 2 a sketch of the tissue with neuro-receptors and the anesthetic zone, which is formed laterally next to the ultrasound generator when ultrasound radiation is activated, as well as a needle, the penetration of which into the tissue is not reported during neuroinhibition; Fig. 3 a sketch of the divergent ultrasonic radiation when the ultrasonic generator is formed from a plurality of piezo elements, a transducer array; Fig. 4 a sketch of the appropriate application of the pain inhibitor, with the created anesthetic zone shown as a small elliptical bulge from the rounded rectangular contact surface; Fig. 5 a sketch of possible positions of additional ultrasound transducer arrays for radiating focused ultrasound into deep neuro-receptors near the neck, spine or pelvis.
[0015] Out of Fig. Figure 1 shows an example of the inventive geometry of the ultrasound irradiation (40). A simple piezo transducer (10) is controlled by a voltage signal that radiates an ultrasound frequency from the interval between 100 kHz and 900 kHz, pulsed with a pulse duration from the interval 0.1 to 3 milliseconds, into an angled attachment (20). A maximum of 30 pulses per second are emitted with the same pulse spacing, where the pulse spacing refers to the time period between two consecutive pulse starts. The generated ultrasound (40) initially propagates to the underside of the attachment (20), which underside is provided as a contact surface (30) for contacting the patient's skin (60). The attachment (20) is typically made of a plastic whose acoustic impedance is close to that of the patient's tissue (60). Contact gel can also be provided between the contact surface (30) and the patient's skin (60) for improved impedance matching.
[0016] In the Fig. 1, one side length of the angled attachment (20) is dimensioned exactly as large as the depth of the Fresnel zone (near field, NF), in which the non-divergent near-field propagation of the US waves occurs. Beyond this distance from the sound source (10), the far-field propagation is assumed to be in the Fraunhofer zone (far field, FF), which is determined by the occurrence of the beam divergence angle Φ div > 0 relative to the incident beam direction 20° < Φ inc < 70°. As already mentioned, the natural beam divergence depends on the ultrasound parameters and is therefore dependent on the choice of the piezoelectric transducer (10), which is not intended to be definitively determined here. However, the inventor's considerations for the frequency range of the ultrasound radiation (40) aimed for here lead to the conclusion that Φ divcan conveniently assume a value in the range 20° to 70°. For each specific design of the ultrasound generator (10), this value can be determined using equation (1). To create an anesthetic zone in the immediate vicinity of the skin surface and laterally adjacent to the ultrasound generator (10), the beam direction of the ultrasound (40) is now at an angle Φ inc against the normal of the contact surface (30) so that the condition Φinc+Φdiv≈90° is fulfilled. The angle of incidence Φ inc should therefore be approximately the complement angle to the beam divergence Φ div correspond; it must also be set to a value between 20° and 70°. Then, a portion of the ultrasound (40) also propagates approximately along the skin surface, and the desired anaesthetic zone results in the area of the tissue (60) which is affected by ultrasound pulses (40) with an intensity averaged over the pulse interval of at least 20 mW / cm 2Due to the known attenuation of the ultrasound intensity during propagation through a tissue (60) - and due to the beam divergence - the irradiated intensity must be at least 20 mW / cm 2 preferably even to a higher value, but with an upper limit of 100 mW / cm 2 should not be exceeded to safely avoid heating of the tissue (60). Neurostimulation to inhibit pain conduction in the anesthetic zone is not thermal, but rather mechanical.
[0017] In Fig. 2 shows a sketch of the skin tissue (60) of a patient with embedded neuroreceptors (70) and synapses (80) for pain transmission via nerve fibers (90). From the contact surface (30) of the ultrasound device according to the invention resting on the skin surface, a divergent ultrasound beam (40) is projected at an angle Φ incagainst the normal of the contact surface (30). The area of tissue (60) surrounded by the marked beam edges, in which sufficiently high US intensity is present, is the temporarily generated anesthetic zone. The insertion of a cannula or needle (50) into this area is not reported to the brain during the activity of the ultrasound generator (10). Shortly after the ultrasound beam (40) is switched off, the local anesthetic is removed, and pain conduction functions normally again.
[0018] To generate a divergent ultrasonic beam (40) emanating directly from the contact surface (30), in addition to the aforementioned natural divergence, a device-induced beam divergence can also be introduced. To this end, it is generally expedient to ensure, by means of equipment, that the sound pressure wave front emanating from the ultrasonic generator (10), which is usually initially flat, reaches the center of the contact surface (30) earlier than the edges of the contact surface (30). One advantageous possibility is to provide an attachment (20) on the ultrasonic generator (10) which implements a diverging acoustic lens (cf. also, for example, US 2002 / 0 032 393 A1). For this purpose, the attachment (20) can be formed, for example, from a plastic (usually a polymer) with a density and / or sound velocity gradient such that higher values are present in the center than at the edge of the contact surface (30).Alternatively, a convex deformation of the contact surface (30) can also be considered, so that a predetermined central region of the contacted skin surface experiences the arrival of the wavefront ahead of all surrounding areas. The wavefront entering the tissue (60) is thus also convexly deformed and leads to a divergent beam (40). The deformation of the contact surface (30) can also be deliberately asymmetrical—in particular, not rotationally symmetrical—which then also imparts an angular deflection Φ to the wavefront. inc can memorize.
[0019] In the simplest case, the device according to the invention can thus comprise a single piezo element (10) and an attachment (20) arranged between the piezo element and the skin surface, wherein the attachment Φ inc complete and Φ divFrom what has been said so far, it should be clear to the person skilled in the art that the normal of the contact surface (30) against which Φ inc measured, in the case of a deformed contact surface (30), is to be understood as a mean normal. Likewise, the direction of incidence of a divergent ultrasonic beam (40) is to be understood as the mean direction of incidence.
[0020] Another, technically more complex possibility for generating divergent and at the same time specifically directed ultrasound radiation (40) is the use of an ultrasound array (100), as shown in Fig. 3. The array (100) shown therein - one- or two-dimensional - consists of individually controllable piezo elements and can form a flat contact surface (30), which is typically acoustically coupled to the patient's skin using a contact gel. Due to the now possible separate control (200) of each piezo element with pulsed signals in any sequence and with any time delay, largely any desired ultrasound wavefronts (300) can be generated in the tissue (60), including those useful for the device according to the invention. The main disadvantage of an array (100) lies in its cost, both for the piezo elements and for the control device designed for a more complex separate control (200). For anesthesia exclusively near the skin surface, technically simpler solutions as described above are preferable.
[0021] Using the example of anesthetizing an injection, a helpful hint for the use of the pain inhibitor should be given: In Fig. Figure 4 shows parts of the human anatomy onto which the pain inhibitor is placed and preferably fixed by means of an adhesive. Medical adhesives, which also contribute to improved ultrasound coupling into the tissue (60), are commercially available, for example as double-sided adhesive patches. The contact surface (30) of the pain inhibitor is in Fig. 4 is drawn in a rounded rectangular shape. A small elliptical bulge protrudes from the contact surface (30) in the sketch, indicating the location of the anaesthetic zone created during operation. The injection should be made into this area. Fig. Figure 4 also shows that the anesthetic zone should preferably be located on the side of the contact surface (30) facing away from the patient's brain. In other words, it is recommended that the ultrasound (40) always be directed toward the brain in the opposite direction to the direction of pain conduction of the nerve fibers (90). This is considered the most reliable method of pain inhibition.
[0022] Since the anesthetic zone only develops upon activation of the ultrasound radiation (40) and is not visible to the user, generally the physician, even during operation of the device, it is an advantageous embodiment of the invention to provide a visible marking during operation of the component of the predetermined radiation direction directed along the contact surface (30). This marking can consist of a simple arrow marking on the side of the contact surface (30) facing away from the patient. The user can then always see on which side of the contact surface (30) the anesthetic zone is created. The user can then select the injection site, for example, approximately 1 cm from the edge of the contact surface (30) on the marked side.
[0023] However, one embodiment considered particularly advantageous is that the at least one ultrasound generator (10) is embedded in a molded body, the shape of the molded body being designed to identify the component of the radiation direction. The molded body can consist of a variety of castable or printable materials, for example a polymeric thermoset or a silicone. The molded body can also serve for further system integration of the pain inhibitor, especially when a single piezo element (10) is to be used together with an attachment (20) - as described above - in the pain inhibitor. These components (10, 20) can be embedded together in a predetermined arrangement in the molded body, such that the molded body has the clearly visible contact surface (30) on exactly one of its outer surfaces.The user only needs to ensure the correct positioning of this contact surface (30) and does not require any knowledge of the details of the ultrasonic generator (10, 20). In a further embodiment, the control device can also be integrated into the molded body, as this can be an electronic circuit with minimal to no programmability, which can be purchased as a microcomponent.
[0024] In an embodiment considered advantageous, the control device can set one of several different operating modes using a single selection button, which differ, for example, in terms of pulse duration and / or pulse spacing and / or ultrasound intensity. Such a selection button can also be integrated into the molded body, for example, on the outer surface opposite the contact surface (30). Elements for displaying the operating mode, preferably an LCD display, can also be arranged there.
[0025] It can be considered particularly advantageous if the electrical voltage source can also be relocated inside the molded body. This is fundamentally possible by providing a miniature battery or an energy storage module and leads to the considerable advantage that the pain inhibitor can operate autonomously without any cable connection. It can therefore be placed anywhere on the patient by the user without any effort, and the patient can even be moved or move themselves while the pain inhibitor is in operation. It can be expedient not only to adhere the pain inhibitor to the patient's skin at its contact surface (30), but also to provide an additional strap securing it, or alternatively to apply a cuff or bandage to prevent the molded body from slipping.
[0026] As already mentioned, the anesthetic zone extends laterally next to the contact surface (30) along the direction of incidence of the ultrasound (40) over a certain length that the doctor wishing to administer an injection cannot reliably determine. To simplify this task somewhat, the pain inhibitor according to the invention can also have a design for selecting the distance. One such advantageous design consists in the shaped body already provided for marking the direction of incidence being not simply continuous and having at least one recess along the predetermined direction of incidence. The recess thus marks a region of the patient intended for injection, exposed to ultrasound radiation (40), in which region the pain conduction is inhibited and through which the patient's skin (60) is directly accessible to the injection needle (50). The doctor can therefore simply administer the injection through the recess.The possibilities for system integration into a molded body with at least one recess described above also exist.
[0027] The pain inhibitor described so far is specifically designed to suppress pain conduction from an anesthetic zone close to the skin's surface. In addition to local anesthesia for injections, a potentially highly sought-after application is the suturing of superficial, gaping wounds.
[0028] If one now also considers deeper wounds or surgical interventions, e.g., biopsies, in deep-lying tissue, one can conclude that, despite the increased costs, an advantageous embodiment of the invention can be for the device to comprise an ultrasound transducer array (100), wherein the array elements are subjected to predetermined voltage signals offset from one another by the control device. Since, according to the invention, the pulse rate is limited to a maximum of 30 pulses per second with the same pulse spacing, and the pulse spacing can therefore be at least 33 ms, but preferably well over 100 ms, up to even more than one second, there is sufficient time between the pulses to use the ultrasound array (100) for a purpose other than emitting divergent ultrasound (40).In particular, ultrasound beams (45) can be emitted intermittently—and at the same low pulse rate—directly into deeper tissue and focused there at any location within a predetermined region. In other words, the device is preferably provided with a control device configured to cause the ultrasound transducer array (100) to irradiate ultrasound (40, 45) in a divergent and focused manner in time.
[0029] It should be noted here that the focused ultrasound (45) often has to pass through bone tissue during propagation into deep tissue, so that for this purpose an ultrasound frequency from the interval of 100 kHz to 600 kHz should be selected.
[0030] Under certain circumstances, it may also be difficult to use an ultrasound transducer array (100) arranged to create an anesthetic zone close to the skin surface while simultaneously exposing a region deep in the tissue to pain-inhibiting ultrasound. For example, it may sometimes be more effective to radiate the focused ultrasound (45) from the side of the patient's body opposite the anesthetic zone. Focused ultrasound (45) generally has an intensity maximum in the ultrasound focus, and thus it is possible to provide relatively small tissue areas inside the body with pain-inhibiting US radiation using low radiation intensities from the individual elements of the ultrasound transducer array (100), while the surrounding tissue remains unanesthetized because the US intensity occurring there is not yet sufficient.The device according to the invention should not be understood in a limited sense; rather, it is also considered an advantageous embodiment that the at least one divergently radiating ultrasound generator (10, 20) and the ultrasound transducer array (100) are each designed as separately positionable units. In particular, the divergently radiating ultrasound generator (10, 20) does not itself need to be designed as an ultrasound transducer array (100) in this case. Fig. 5 shows by way of example that ultrasound transducer arrays (100) can be arranged to irradiate focused ultrasound (45) into the neck, the area surrounding the spine and / or the pelvic region in order to cause pain inhibition in deep-lying neuro-receptors.
[0031] Specifically, to avoid the sensation of pain during a biopsy of tissue (60) located deep beneath the skin's surface, the physician naturally strives to provide the entire path from the insertion site of the biopsy needle (50) to the target tissue with appropriate anesthesia. The device according to the invention can take advantage of the fact that the ultrasound focus can be shifted very quickly within the patient's body by the control device and that the relatively large pulse spacing allows a large number of different focus positions to be controlled intermittently. Particularly preferably, the control device is designed to cause the ultrasound transducer array (100) to generate an ultrasound focus in a predetermined region of the patient's tissue (60) and to continuously change the position of the ultrasound focus within the region.The focus positions can be randomly selected within a region or scanned according to a predetermined grid. This is also referred to as "fanning" of the ultrasound (45), a typically periodic angular change in the beam direction, which leads to a focus shift along predetermined lines. For a biopsy, for example, the entire puncture channel, from the skin-near anesthetic zone down to the target tissue of the biopsy, and its surroundings, can be defined as the region that the variably positioned US focus must scan and locally anesthetize.
[0032] Biopsies are commonly performed under physician supervision using an ultrasound imaging device. Such devices use ultrasound frequencies in the megahertz range for their high image resolution, and adverse interference with the pain-inhibiting, low-intensity, pulsed kilohertz US (40, 45) is not expected. However, an ultrasound imaging device can provide useful information about the imaged region of the patient and pass it on to the pain inhibitor's control unit to guide the movement of the ultrasound focus.Provided that the fixed position of the at least one ultrasound transducer array (100) of the pain inhibitor relative to the sensor head of the US imaging device is known in advance or can at least be determined with sufficient accuracy at any time, the region to be anesthetized can, for example, be automatically aligned with the currently imaged region at any time, with the attending physician having selected this imaged region for observation of the procedure. In particular, a biopsy needle can also be located in the US image, and a—possibly tubular—surrounding the needle can be automatically selected as the target area for anesthesia and continuously adjusted during the procedure.
[0033] Thus, it can be advantageous for an ultrasound device for pain inhibition according to the invention, which comprises at least one ultrasound transducer array (100), to also have at least one interface for data-exchanging communication between the control device and an ultrasound imaging device. In this case, it can be considered particularly advantageous for the control device to be designed to receive and evaluate image information from the ultrasound imaging device and to cause the ultrasound transducer array to generate and, if necessary, also move the ultrasound focus within the imaged region.
[0034] However, the basic design of the pain inhibition device according to the invention requires only a divergent and laterally directed ultrasound generator (10, 20) and is fully suitable for anesthetizing tissue close to the skin's surface. Replacement or additional ultrasound transducer arrays (100) can be considered upgrades to also inhibit deep nerves below the skin-near anesthetic zone through neurostimulation.
Claims
[1] Ultrasound device for the local inhibition of pain conduction comprising at least one piezoelectric ultrasound generator (10, 100) with a contact surface (30) for ultrasound-transmitting contact with the skin surface of a patient, an electrical voltage source and a control device for applying predetermined voltage signals to the at least one ultrasound generator (10, 100), characterized by , that a. the control device is designed to cause the at least one ultrasound generator (10, 100) to generate pulsed ultrasound with an ultrasound frequency from the interval of 100 kHz to 900 kHz b. and a pulse duration from the interval of 0.1 to 3 milliseconds, where c. maximum 30 pulses per second with equal pulse spacing d. with an ultrasound intensity averaged over the pulse interval from the interval of 20 to 100 mW / cm 2are generated and means (20, 100) are provided for setting up a divergent ultrasonic radiation (40) with a predetermined radiation direction, which has an angle of incidence Φ inc between 20° and 70° with the normal of the contact surface (30), wherein the angle of incidence Φ inc and an opening angle of the divergent ultrasonic radiation Φ div are chosen such that the condition Φ inc + Φ div ≈ 90 is satisfied, so that the angle of incidence Φ inc at least approximately the complement angle of the opening angle of the divergent ultrasonic radiation Φ div corresponds. [2] Ultrasonic device according to claim 1 characterized by an identification, visible during operation, of the component of the predetermined beam direction directed along the contact surface (30). [3] Ultrasonic device according to claim 2, characterized bythat the at least one ultrasound generator (10, 100) is embedded in a shaped body, wherein the shape of the shaped body is designed to identify the component of the radiation direction. [4] Ultrasonic device according to claim 3, characterized by that the shaped body is not simply formed in a continuous manner and has at least one recess along the predetermined direction of incidence. [5] Ultrasound device according to one of the preceding claims, characterized by that the device comprises an ultrasonic transducer array (100), wherein array elements are provided which are supplied by the control device with predetermined voltage signals offset from one another. [6] Ultrasonic device according to claim 5, characterized by that the control device is designed to cause the ultrasonic transducer array (100) to irradiate ultrasound (40, 45) in a time-alternating and divergent manner. [7] Ultrasonic device according to claim 5, characterized by that at least one divergently radiating ultrasound generator (10, 20) is provided, wherein the divergently radiating ultrasound generator (10, 20) and the ultrasound transducer array (100) are each designed as separately placeable units. [8] Ultrasonic device according to one of claims 5 to 7, characterized by in that the control device is designed to cause the ultrasound transducer array (100) to generate an ultrasound focus in a predetermined region of the patient's tissue (60) and to continuously change the position of the ultrasound focus within the region. [9] Ultrasound device according to one of the preceding claims, characterized by at least one interface for data-exchanging communication between the control device and an ultrasound imaging device. [10] Ultrasonic device according to claims 8 and 9, characterized byin that the control device is designed to receive and evaluate image information from the imaging ultrasound device and to cause the ultrasound transducer array (100) to generate the ultrasound focus within the imaged region.
Citation Information
Patent Citations
Ultrasound application device for accelerating sternum healing
US20020032393A1
Method and apparatus for reducing / suppressing pain in digits
US20120203141A1
Low-profile ultrasound transducer
US20130006153A1
Stimulation apparatus using low intensity focused ultrasound for pain management and muscle strengthening
US20160016012A1
